Cessation of Hormone Replacement Therapy After Reports of Adverse Findings From Randomized Controlled Trials: Evidence From a British Birth Cohort
- 1 July 2006
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 96 (7) , 1219-1225
- https://doi.org/10.2105/ajph.2005.071332
Abstract
Objectives. We examined the cessation of hormone replacement therapy (HRT) among British women, by educational level, social class, and cardiovascular risk factors, at the time of publicity about 2 clinical trials of HRT that were halted after adverse findings. Methods. A total of 1387 women aged 57 years reported their monthly HRT use between January 2002 and February 2003. A succession of regression-based time-series models were fitted to detect changes in the proportion of HRT users stratified by education level, social class, hypertension, and obesity. Results. The overall percentage of HRT users declined from 31% in January 2002 to less than 26% by February 2003. Changes in trends of HRT use were first detected in June 2002 (for women with advanced secondary educational qualification or higher) and in July 2002 (for all other groups). The rate of decline was greatest for women with no formal educational qualifications, from the manual social class, or who were hypertensive or obese. Conclusions. These decreases coincided with the announced cessation of a large US clinical trial of HRT. This publicity may have had a differential influence on the immediate decline in HRT use by various groups of British women.Keywords
This publication has 17 references indexed in Scilit:
- Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectivesJournal of Epidemiology and Community Health, 2005
- The validity of self‐reported use of hormone replacement therapy among Danish nursesActa Obstetricia et Gynecologica Scandinavica, 2004
- National Use of Postmenopausal Hormone TherapyJAMA, 2004
- Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapyObstetrics & Gynecology, 2003
- Misleading media reporting? The MMR storyNature Reviews Immunology, 2003
- Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of usersBMJ, 2003
- Birthweight, childhood social class, and change in adult blood pressure in the 1946 British birth cohortThe Lancet, 2003
- Women's health in midlife: findings from a British birth cohort studyPost Reproductive Health, 2003
- The life course prospective design: an example of benefits and problems associated with study longevitySocial Science & Medicine, 2003
- Misled and confused? Telling the public about MMR vaccine safety: Table 1Journal of Medical Ethics, 2003